Pamela Kushner
Family Medicine · Los Angeles, CANPI 1871670828
Payments from drug & device makers
Across 1,280 payments — averaging $931.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$138K
- Novo Nordisk$128K
- Boehringer Ingelheim$121K
- GSK$106K
- Boehringer Ingelheim International GmbH$94K
- AstraZeneca$90K
- plus $515K from 27 others
What the payments were for
- Consulting fees$654,70155%
- Speaking & faculty fees$299,17725%
- Travel & lodging$210,85718%
- Food & beverage$27,8392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 179 | $137,765 |
| Novo Nordisk | 91 | $128,146 |
| Boehringer Ingelheim | 121 | $121,011 |
| GSK | 48 | $105,860 |
| Boehringer Ingelheim International GmbH | 61 | $94,291 |
| AstraZeneca | 137 | $90,376 |
| Abbott | 165 | $89,992 |
| Bayer | 101 | $84,234 |
| Astrazeneca UK Limited | 69 | $71,827 |
| Novo Nordisk AS | 22 | $68,229 |
| Eli Lilly | 54 | $66,089 |
| Corcept Therapeutics | 49 | $28,277 |
| Lilly USA, LLC | 80 | $27,749 |
| Regeneron | 21 | $13,964 |
| Currax Pharmaceuticals LLC | 13 | $11,468 |
| Phathom Pharmaceuticals, Inc. | 13 | $9,557 |
| Idorsia Pharmaceuticals US Inc | 6 | $8,421 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $6,125 |
| Azurity Pharmaceuticals, Inc. | 8 | $4,796 |
| Astellas Pharma US Inc | 3 | $4,586 |
| Amgen | 7 | $4,228 |
| Shield Therapeutics Inc | 1 | $3,150 |
| Biogen | 1 | $3,132 |
| Janssen Scientific Affairs, LLC | 3 | $2,874 |
| Kowa Pharmaceuticals America, Inc. | 5 | $2,218 |
| Orapharma, A Division Of Bausch Health US, LLC | 1 | $1,313 |
| Intuity Medical Inc | 1 | $1,260 |
| Tonix Medicines, Inc. | 3 | $828 |
| Esperion Therapeutics, Inc. | 4 | $357 |
| Insmed, Inc. | 1 | $200 |
| Heartflow, Inc. | 1 | $103 |
| Novartis | 2 | $94 |
| Lexicon Pharmaceuticals, Inc. | 2 | $55 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$115,926
- Kerendia$74,712
- JARDIANCE$73,653
- FARXIGA$50,337
- FREESTYLE LIBRE 3$40,825
- Victoza$30,607
- RYBELSUS$27,569
- Korlym$27,194
- FreeStyle Libre$23,350
- Ozempic$22,141
- INVOKANA$21,059
- FreeStyle Libre Pro$19,061
- CONTRAVE$11,335
- VOQUEZNA$9,325
- MOUNJARO$8,850
- QUVIVIQ$8,358
- TRELEGY ELLIPTA$7,515
- Non-Covered$6,924
- XIFAXAN$6,125
- WIDAPLIK$4,645
How this compares
$1,192,574 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Other family medicine in Los Angeles
- Albert NassirLos Angeles$5.7M
- Nader SobhLos Angeles$4.1M
- Alexander RivkinLos Angeles$2.8M
- Scott HowellLos Angeles$793K
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.